Bronchodilatation in vivo by carbon monoxide, a cyclic GMP related messenger

British Journal of Pharmacology

Volumn 124, Issue 6, 1998, Pages 1065-1068

  Cardell, Lars Olaf ^a   Ueki, Iris F ^a   Stjärne, Pär ^a   Agusti, Carlos ^a   Takeyama, Kiyoshi ^a   Lindén, Anders ^a   Nadel, Jay A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Airway; Carbon monoxide; Dilatation; In vivo pharmacology; Lung; Rp 8Br cyclic GMPS; Trachea

Indexed keywords

8 BROMOGUANOSINE PHOSPHATE; CARBON MONOXIDE; CYCLIC GMP; HISTAMINE; N(G) NITROARGININE METHYL ESTER; SALBUTAMOL;

AIRWAY; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BOLUS INJECTION; BRONCHODILATATION; CONCENTRATION RESPONSE; CONTINUOUS INFUSION; CONTROLLED STUDY; GUINEA PIG; INTRAVENOUS DRUG ADMINISTRATION; LUNG RESISTANCE; MALE; NEUROTRANSMISSION; NONHUMAN; PRIORITY JOURNAL; SMOOTH MUSCLE TONE; VASODILATATION;

ANIMALS; BRONCHODILATOR AGENTS; CARBON MONOXIDE; CYCLIC GMP; ENZYME INHIBITORS; GUINEA PIGS; HISTAMINE; LUNG; MALE; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE; OXYGEN; SECOND MESSENGER SYSTEMS;

EID: 0031828998     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0701878     Document Type: Article

References (29)

1. ADAMS, J.D., ERICKSON, H.H. & STONE, H.L. (1973). Myocardial metabolism during exposure to carbon monoxide in the conscious dog. Appl. Physiol., 34, 238-242.
2. AMDUR, M.O. & MEAD, J. (1958). Mechanics of respiratory in unanesthetized guinea pigs. Am. J. Physiol., 192, 364-368.
3. BERTRAND, C., NADEL, J.A., GRAF, P.D. & GEPPETTI, P. (1993). Capsaicin increases airflow resistance in guinea pig in vivo by activating both NK2 and NK1 tachykinin receptors. Am. Rev. Respir. Dis., 148, 909-914.
4. BRIAN, JR. J.E., HEISTAD, D.D. & FARACI, F.M. (1994). Effect of carbon monoxide on rabbit cerebral arteries. Stroke, 25, 639-644.
5. FOSTERMANN, U., MULSCH, A., BOHEME, E. & BUSSE, R. (1986). Stimulation of soluble guanylate cyclase by an acetylcholine-induced endothelium-derived factor from rabbit and canine arteries. Circ. Res., 58, 531-538.
6. FURCHGOTT, R.F. & JOTHIANANDAN, D. (1991). Endothelium-dependent and -independent vasodilation involving cyclic GMP: relaxation induced by nitric oxide, carbon monoxide and light. Blood Vessels, 28, 52-61.
7. GRÄSER, T., VEDERNIKOV, Y.P. & LI, D.S. (1990). Study on the mechanism of carbon monoxide induced endothelium-independent relaxation in porcine coronary artery and vein. Biomed. Biochim. Acta, 49, 293-296.
8. KOEHLER, R.C., JONES, JR. M.D. & TRAYSTMAN, R.J. (1982). Cerebral circulatory response to carbon monoxide and hypoxic hypoxia in the lamb. Am. J. Physiol., 235, H27-H32.
9. LEFER, D.J., MA, X.-L. & LEFER, A.M. (1993). A comparison of vascular biological actions of carbon monoxide and nitric oxide. Methods Find. Exp. Clin. Pharmacol., 15, 617-622.
10. MAINES, M.D. (1988). Heme oxygenase: function, multiplicity, regulatory mechanisms, and clinical applications. FASEB J., 2, 2557-2568.
11. MAINES, M.D. (1993). Carbon monoxide: An emerging regulator of cGMP in the brain. Mol. Cell. Neurosci., 4, 389-397.
12. MARKS, G.S., BRIEN, J.F., NAKATSU, K. & MCLAUGHLIN, B.E. (1991). Does carbon monoxide have a physiological function? Trends Pharmacol. Sci., 12, 185-188.
13. MEILIN, S., ROGATSKY, G.G., THOM, S.R., ZARCHIN, N., GUGGENHEIMER-FURMAN, E. & MAYEVSKY, A. (1996). Effects of carbon monoxide on the brain may be mediated by nitric oxide. J. Appl. Physiol., 81, 1078-1083.
14. MONCADA, S. (1992). Nitric oxide gas: mediator, modulator, and pathophysiologic entity. J. Lab. Clin. Med., 120, 187-191.
15. MORITA, T., PERRELLA, M.A., LEE, M.-E. & KOUREMBANAS, S. (1995). Smooth muscle cell-derived carbon monoxide is a regulator of vascular cGMP. Proc. Natl. Acad. Sci. U.S.A., 92, 1475-1479.
16. NY, L., ALM, P., EKSTRÖM, P., LARSSON, B., GRUNDEMAR, L. & ANDERSSON, K.-E. (1996). Localization and activity of haem oxygenase and functional effects of carbon monoxide in the feline lower oesophageal sphincter. Br. J. Pharmacol., 118, 392-399.
17. NY, L., GRUNDEMAR, L., LARSSON, B., ALM, P., EKSTRÖM, P. & ANDERSSON, K.-E. (1995). Carbon monoxide as a putative messenger molecule in the feline lower oesophageal sphincter of the cat. NearoReport, 6, 1261-1265.
18. RATTAN, S. & CHAKDER, S. (1993). Inhibitory effect of CO on internal and anal sphincter: heme oxygenase inhibitor inhibits NANC relaxation. Am. J. Physiol., 265, G799-G804.
19. RODGERS, P.A., VREMAN, H.J., DENNERY, P.A. & STEVENSON, D.K. (1994). Sources of carbon monoxide (CO) in biological systems and application of CO detection technologies. Seminars Perinatology, 18, 2-10.
20. SCHMIDT, H.H. (1992). NO, CO and OH. Endogenous soluble guanylyl cyclase-activating factors. FEBS Lett., 307, 102-107.
21. TENHUNEN, R., MARVER, H.S. & SCHMID, R. (1968). The enzymatic conversion of heme to bilirubin by microsomal heme oxygenase. Proc. Natl. Acad. Sci. U.S.A., 61, 748-755.
22. UTZ, J. & ULLRICH, V. (1991). Carbon monoxide relaxes ileal smooth muscle through activation of guanylate cyclase. Biochem. Pharmacol., 41, 1195-1201.
23. VERMA, A., HIRSCH, D.J., GLATT, C.E., RONNETT, G.V. & SNYDER, S.H. (1993). Carbon monoxide: a putative neural messenger. Science, 259, 381-384.
24. VREMAN, H.J., MAHONEY, J.J. & STEVENSON, D.K. (1995). Carbon monoxide and carbonyxhemoglobin. Adv. Pediatr., 42, 303-334.
25. VREMAN, H.J. & STEVENSON, D.K. (1988). Heme oxygenase activity as measured by carbon monoxide production. Anal. Biochem., 168, 31-38.
26. WALTER, U. (1989). Physiological role of cGMP and cGMP-dependent protein kinase in the cardiovascular system. Rev. Physiol. Biochem. Pharmacol., 113, 41-88.
27. WARD, J.K., BARNES, P.J., TADJKARIMI, S., YACOUB, M.H. & BELVISI, M.G. (1995). Evidence for the involvement of cGMP in neural bronchodilator response in human trachea. J. Physiol., 483, 525-536.
28. ZHUO, M., HU, Y., SCHULTZ, C., KANDEL, E.R & HAWKINS, R.D. (1994). Role of guanylyl cyclase and cGMP-dependent protein kinase in long-term potentiation. Nature, 368, 635-639.
29. (1)-nitro-L-arginine. Acta Physiol. Scand., 152, 137-143.